Elite Pharmaceuticals

Answer: Elite Pharmaceuticals's phone number is 20********

Answer: Elite Pharmaceuticals's official website is https://elitepharma.com

Answer: Elite Pharmaceuticals's revenue is $25 Million to $50 Million

Answer: Elite Pharmaceuticals's SIC: 2834

Answer: Elite Pharmaceuticals's NAICS: 541711

Answer: Elite Pharmaceuticals has 11-50 employees

Answer: Elite Pharmaceuticals is in Pharmaceuticals

Answer: Elite Pharmaceuticals contact info: Phone number: 20******** Website: https://elitepharma.com

Answer: Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite's strategy includes assisting partner companies in the life cycle management of products, to improve off-patent drug products, and developing generic versions of controlled release drug products with high barriers to entry. Elite has four ANDA products partnered with TAGI Pharma; one ANDA has launched, two ANDAs are in the process of a manufacturing site transfer and an additional ANDA is currently under review by the FDA. Elite also manufactures Lodrane D and receives royalties for Lodrane D, an allergy product partnered with ECR Pharmaceuticals (ECR), a wholly owned subsidiary of Hi-Tech Pharmacal (Hi-Tech). Elites lead pipeline products, ELI-216, a once-daily abuse resistant oxycodone, and ELI-154, a once-daily oxycodone, are novel sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse. Elite also has partnered with Mikah Pharma to develop a new product and with Hi-Tech Pharmacal to develop an intermediate for a generic product. Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.

Answer:

• Facebook
• LinkedIn